Compare Alliant Energy Corporation (LNT) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alliant Energy Corporation vs Natera Inc. Common Stock — how do they compare? Alliant Energy Corporation trades at $67.7 (market cap $17.51B), while Natera Inc. Common Stock trades at $393.27 (market cap $57.03B). The key difference: Natera Inc. Common Stock is far larger — about 3.3× Alliant Energy Corporation's market cap, and Alliant Energy Corporation pays a 3.17% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Alliant Energy Corporation for 65 Days and Natera Inc. Common Stock for 0 Days on average.
| LNT | NTRA | |
|---|---|---|
Market Cap | $17.51B | $57.03B |
Volume | 2,397,331 | 1,131,157 |
Sector | Utilities | Health |
52-Week High | $78.03 | $425.64 |
52-Week Low | $63.21 | $179.42 |
Typical Hold Time | 65 Days | 0 Days |
Enterprise Value | $29.60B | $56.18B |
Dividend Yield | 3.17% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LNT trades at $66.96, up 0.75% today, with a bullish technical signal despite mixed momentum indicators. The company shows strong fundamentals with Q2 2026 EPS beating expectations at $0.65 versus $0.579, and revenue growth to $4.36B in 2025. Recent news highlights a $1.4B partnership with CareTrust REIT and institutional buying interest.
Outlook remains positive with analyst consensus price target of $74.00 (10.5% upside) and no sell ratings. Key risks include rising debt levels (debt-to-asset ratio up to 48.48% in 2025) and execution of $13.4B capital expenditure plan. The stock offers defensive utility exposure with 23-year dividend growth.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
